checkAd

    DEADLINE ALERT  381  0 Kommentare Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Helius Medical Technologies (NASDAQ: HSDT) and Encourages Helius Investors to Contact the Firm

    Bragar Eagel & Squire, P.C. announces that a class action lawsuit has been filed in the United States District Court for the Southern District of New York on behalf of all investors that purchased Helius Medical Technologies, Inc. (NASDAQ: HSDT) securities between November 9, 2017 and April 10, 2019 (“the “Class Period”). Investors have until September 9, 2019 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

    Click here to participate in the action.

    The complaint, filed on July 9, 2019, alleges that throughout the Class Period, defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, defendants failed to disclose to investors: (1) that the clinical study on the use of PoNS did not produce statistically significant results regarding the effectiveness of the treatment; (2) that, as a result, the clinical study did not support the company’s application for regulatory clearance; (3) that, as a result, the company was unlikely to receive regulatory approval of PoNS; and (4) that, as a result of the foregoing, defendants’ positive statements about the company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

    If you purchased Helius shares during the Class Period, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Melissa Fortunato by email at investigations@bespc.com, or telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you.

    Bragar Eagel & Squire, P.C. is a New York-based law firm concentrating in commercial and securities litigation. For additional information concerning the Helius lawsuit, please go to https://bespc.com/HSDT. For additional information about Bragar Eagel & Squire, P.C. please go to www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes.



    Business Wire (engl.)
    0 Follower
    Autor folgen

    DEADLINE ALERT Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Helius Medical Technologies (NASDAQ: HSDT) and Encourages Helius Investors to Contact the Firm Bragar Eagel & Squire, P.C. announces that a class action lawsuit has been filed in the United States District Court for the Southern District of New York on behalf of all investors that purchased Helius Medical Technologies, Inc. (NASDAQ: HSDT) …